Endo Shares Outstanding 2006-2019 | ENDP

Endo shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Endo Annual Shares Outstanding
(Millions of Shares)
2018 224
2017 223
2016 223
2015 197
2014 157
2013 120
2012 116
2011 121
2010 118
2009 118
2008 124
2007 135
2006 134
2005 133
Endo Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 225
Q4 2018 224
Q3 2018 224
Q2 2018 224
Q1 2018 224
Q4 2017 223
Q3 2017 223
Q2 2017 223
Q1 2017 223
Q4 2016 223
Q3 2016 223
Q2 2016 223
Q1 2016 222
Q4 2015 197
Q3 2015 209
Q2 2015 185
Q1 2015 177
Q4 2014 157
Q3 2014 159
Q2 2014 163
Q1 2014 128
Q4 2013 120
Q3 2013 120
Q2 2013 117
Q1 2013 113
Q4 2012 116
Q3 2012 120
Q2 2012 121
Q1 2012 117
Q4 2011 121
Q3 2011 121
Q2 2011 123
Q1 2011 121
Q4 2010 118
Q3 2010 117
Q2 2010 117
Q1 2010 118
Q4 2009 118
Q3 2009 118
Q2 2009 117
Q1 2009 117
Q4 2008 124
Q3 2008 120
Q2 2008 124
Q1 2008 135
Q4 2007 135
Q3 2007 135
Q2 2007 135
Q1 2007 134
Q4 2006 134
Q3 2006 134
Q2 2006 134
Q1 2006 134
Q4 2005 133
Q3 2005 134
Q2 2005 133
Q1 2005 133
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.812B $2.947B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.313B 34.70
Takeda Pharmaceutical (TAK) Japan $27.201B 7.99
Grifols (GRFS) Spain $13.779B 17.43
Sage Therapeutics (SAGE) United States $9.044B 0.00
Ionis Pharmaceuticals (IONS) United States $8.958B 19.58
Neurocrine Biosciences (NBIX) United States $7.714B 0.00
Catalent (CTLT) United States $7.679B 30.82
Jazz Pharmaceuticals (JAZZ) Ireland $7.437B 10.19
Nektar Therapeutics (NKTR) United States $5.907B 9.63
Tilray (TLRY) Canada $4.670B 0.00
FibroGen (FGEN) United States $3.751B 0.00
United Therapeutics (UTHR) United States $3.332B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.309B 11.61
Arrowhead Pharmaceuticals (ARWR) United States $2.607B 392.86
PTC Therapeutics (PTCT) United States $2.470B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.924B 6.92
Xencor (XNCR) United States $1.909B 52.11
Portola Pharmaceuticals (PTLA) United States $1.796B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.781B 86.24
Zogenix (ZGNX) United States $1.730B 0.00
Tricida (TCDA) United States $1.720B 0.00
USANA Health Sciences (USNA) United States $1.688B 14.67
Enanta Pharmaceuticals (ENTA) United States $1.630B 22.28
Ironwood Pharmaceuticals (IRWD) United States $1.590B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.557B 0.00
Heron Therapeutics (HRTX) United States $1.406B 0.00
Aerie Pharmaceuticals (AERI) United States $1.387B 0.00
Turning Point Therapeutics (TPTX) United States $1.322B 0.00
Esperion Therapeutics (ESPR) United States $1.309B 0.00
Corcept Therapeutics (CORT) United States $1.190B 16.98
ArQule (ARQL) United States $1.094B 0.00
Radius Health (RDUS) United States $1.078B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.916B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.899B 0.00
Aptorum Group (APM) China $0.755B 0.00
Odonate Therapeutics (ODT) United States $0.751B 0.00
CannTrust Holdings (CTST) Canada $0.706B 0.00
Organogenesis Holdings (ORGO) United States $0.658B 0.00
Translate Bio (TBIO) United States $0.638B 0.00
TherapeuticsMD (TXMD) United States $0.603B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.567B 0.00
Dermira (DERM) United States $0.510B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
ChemoCentryx (CCXI) United States $0.495B 0.00
GlycoMimetics (GLYC) United States $0.485B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Siga Technologies (SIGA) United States $0.450B 1.06
BioSpecifics Technologies Corp (BSTC) United States $0.420B 21.18
Flexion Therapeutics (FLXN) United States $0.414B 0.00
Collegium Pharmaceutical (COLL) United States $0.414B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.400B 0.00
Karyopharm Therapeutics (KPTI) United States $0.386B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.371B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.370B 0.00
KalVista Pharmaceuticals (KALV) United States $0.367B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.349B 0.00
TCR2 Therapeutics (TCRR) United States $0.349B 0.00
Rafael Holdings (RFL) United States $0.334B 0.00
Forty Seven (FTSV) United States $0.333B 0.00
Harpoon Therapeutics (HARP) United States $0.309B 0.00
Molecular Templates (MTEM) United States $0.299B 0.00
OptiNose (OPTN) United States $0.298B 0.00
Xeris Pharmaceuticals (XERS) United States $0.291B 0.00
CASI Pharmaceuticals (CASI) United States $0.290B 0.00
ImmunoGen (IMGN) United States $0.280B 0.00
Concert Pharmaceuticals (CNCE) United States $0.271B 0.00
Dova Pharmaceuticals (DOVA) United States $0.264B 0.00
Aratana Therapeutics (PETX) United States $0.246B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.238B 0.00
Minerva Neurosciences (NERV) United States $0.231B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.225B 0.00
Lannett Co Inc (LCI) United States $0.222B 2.15
Recro Pharma (REPH) United States $0.215B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.200B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.196B 0.00
Aldeyra Therapeutics (ALDX) United States $0.195B 0.00
Opexa Therapeutics (ACER) United States $0.194B 0.00
Bio Blast Pharma (ENLV) Israel $0.188B 0.00
Galectin Therapeutics (GALT) United States $0.187B 0.00
Ocular Therapeutix (OCUL) United States $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
MEI Pharma (MEIP) United States $0.183B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.182B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.169B 0.00
Nature's Sunshine Products (NATR) United States $0.160B 51.88
Ardelyx (ARDX) United States $0.159B 0.00
Calithera Biosciences (CALA) United States $0.152B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
IMV INC (IMV) Canada $0.148B 0.00
AgeX Therapeutics (AGE) United States $0.148B 0.00
Jounce Therapeutics (JNCE) United States $0.147B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Majesco Entertainment (PTE) United States $0.138B 0.00
Neon Therapeutics (NTGN) United States $0.131B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Tyme Technologies (TYME) United States $0.114B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.103B 0.00
DURECT (DRRX) United States $0.102B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
Avenue Therapeutics (ATXI) United States $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.098B 70.00
Bellicum Pharmaceuticals (BLCM) United States $0.097B 0.00
China SXT Pharmaceuticals (SXTC) China $0.096B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Champions Oncology (CSBR) United States $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.092B 0.00
Cardiome Pharma (CORV) Canada $0.092B 0.00
MediWound (MDWD) Israel $0.088B 0.00
Natural Alternatives (NAII) United States $0.088B 8.80
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.081B 0.00
Capnia (SLNO) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.078B 0.00
Novan (NOVN) United States $0.072B 0.00
Melinta Therapeutics (MLNT) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Zafgen (ZFGN) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.046B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.045B 0.00
KemPharm (KMPH) United States $0.044B 0.00
Lipocine (LPCN) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.033B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.032B 0.00
PharmAthene (ALT) United States $0.030B 0.00
IsoRay (ISR) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
GTx (ONCT) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Pain Therapeutics (SAVA) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.64
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.81
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00